Nycomed Presentation Template for PowerPoint 2000

Report
<BB_TITLE>
<DATA_TO>
R3D1
MDI
R3D1
DPI
R3D1
Nebuls
R3F1
MDI
R3F1
DPI
R3F1
Nebuls
R3
Other
All Products from R3D1
when the second letter of the
3 letter Form Code is ‘H’
All Products from R3D1
when the second letter of the
3 letter Form Code is ‘E’ or ‘C’
All Products from R3D1
when the second letter of the
3 letter Form Code is ‘G’
All Products from R3F1
when the second letter of the
3 letter Form Code is ‘H’
All Products from R3F1
when the second letter of the
3 letter Form Code is ‘E’ or ‘C’
All Products from R3F1
when the second letter of the
3 letter Form Code is ‘G’
All Products from R3
excluding R3D1 and R3F1
Takeda
Segment 3
Takeda
Segment 2
Takeda
Segment
Market
Alvesco Market Definitions
Alvesco Market
R3
Mono
R3D1
MDI + DPI
Combined
Combi
R3F1
Nebuls
MDI + DPI
Combined
Other
All Products from R3
excluding R3D1 and R3F1
Nebuls
<BB_TITLE>
<DATA_TO>
Market
Calcium Market Definitions
Takeda
Segment 2
Takeda
Segment
Calcium Market A12A
Total (LOCs + Partners)
LOCs
Partners
LOCs Takeda
Performance
LOCs
Competitors
Partners Takeda
Performance
Partners
Competitors
All Takeda sales for
A12A from all
countries excluding
UK, France,
Germany, Italy
and Canada
All sales for A12A for
Corporations
excluding Takeda
from all countries
excluding UK, France,
Germany, Italy
and Canada
All Calcium sales for
A12A from countries
UK, France,
Germany, Italy
and Canada
All sales for A12A for
Corporations
excluding Takeda
from countries
UK, France,
Germany, Italy
and Canada
<BB_TITLE>
<DATA_TO>
Circadin Market Definitions
Takeda
Segment 2
Takeda
Segment
Market
Circadin Market
All N5B1
Benzo
All Products from N5B1where
molecule combination does NOT start
with ‘Z’ and excluding melatonin
Circadin
Product Circadin only
Takeda Circadin
Austria, Belgium, Denmark,
Finland, Greece,
Netherlands, Norway, Sweden
Non Benzo
All Products from N5B1 where
molecule combination DOES
start with ‘Z’
Lundbeck Circadin
Czech Republic, France, Germany,
Hungary, Ireland, Poland, Portugal
Slovakia, Spain, United Kingdom
Note : This market is restricted to the following countries
Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Germany, Hungary, Ireland
Netherlands, Norway, Poland, Portugal, Slovakia, Spain, Sweden, United Kingdom
S
<BB_TITLE>
<DATA_TO>
Market
Daxas Market Definition
Daxas Market
ATC R3
<BB_TITLE>
<DATA_TO>
Market
Instanyl Market Definition
Instanyl Market
International Products Actiq, Abstral, Effentora, Instanyl and Pecfent from N2A
<BB_TITLE>
<DATA_TO>
Market
Matrifen Market Definitions
Takeda
Segment 4
Takeda
Segment 3
Takeda
Segment 2
Takeda
Segment
Matrifen Market N2A
Sustained Release Opioids
Immediate Release Opioids
Oral Solid
Ordinary
N2A NFC A
Oral Liquid
Ordinary
N2A NFC D
Parental
Ordinary
N2A NFC F
Other
(Rec. Topic. OTH)
N2A Excl NFC
A, B, D, E, F, G
JWM, JWN
Matrifen Market
(Fentanyl Patches)
N2A Plain Buprenorphine
NFC JWN
Transdermal
Patches
N2A NFC
JWM, JWN
Buprenorphine Patches
N2A Plain Buprenorphine
NFC JWN
3 – 4 Day Duration Patches
N2A Plain Excl. Local Product
Butrans and Norspan
Oral Solid &
Liquid Retard
N2A NFC B, E
Other Molecules /
Other Duration Patches
Local Product Ionsys
and/or NFC JWM and
molecule sufentanil NFC JWN
7 Day Duration Patches
Local Product
Butrans and Norspan
<BB_TITLE>
<DATA_TO>
Market
Omnaris Market Definition
Omnaris Market
All products from R1A1
<BB_TITLE>
<DATA_TO>
Takeda
Segment
Market
Pantoprazole Market Definitions
Pantoprazole Market
A2B2
PPI
All A2B2 combinations of the following
molecules: pantoprazole, esomeprazole,
omeprazole, rabeprazole, lansoprazole,
dexlansoprazole
A2B2 Others
All remaining A2B2
<BB_TITLE>
<DATA_TO>
Takeda
Segment 2
Takeda
Segment
Market
Preotact Market Definitions
Osteoporosis Market
PTH Market
Osteoporosis
Others
Preotact Market
Preotact
Broad Market
Osteoporosis
Other Sub
All International
Products
Forteo and Preotact
All International
Product
Protelos
Al Products from
M5B, G3J and H4E
(except Forteo,
Preotact, Protelos)
Note: This market is limited to the following countries –
Austria, Czech Republic, Denmark, Finland, Germany, Greece, Ireland, Italy,
Netherlands, Norway, Portugal, Slovakia, Spain, Sweden and UK
<BB_TITLE>
<DATA_TO>
Market
TachoSil Market Definition
TachoSil Market
All Products from B2F and B2G
<BB_TITLE>
<DATA_TO>
Xefo Market Definitions
Coxibs
NSAIDS
Coxibs
NSAIDS +
Coxibs
All Products
from M1A1
and M1A3
excl NFC1 A, B,
F or G
N2B
All
Products
from N2B
excl NFC1
A, B, F or G
NSAIDS
Coxibs
All Products from M1A3
excl NFC1 A, B, F or G
NSAIDS
IV Forms
All Products from M1A1
excl NFC1 A, B, F or G
Coxibs
All Products from M1A3
with NFC1 F or G
NSAIDS
All Products from M1A1
with NFC1 F or G
NSAIDS +
N2B
N2B
Coxibs
All
All
All Products
Products
Products
from M1A1
from N2B
from N2B
and M1A3
with NFC1
with NFC1
with
NFC1
F
or
G
A or B
F or G
All Products from M1A3
with NFC1 A or B
NSAIDS +
Coxibs
All Products
from M1A1
and M1A3
with NFC1 A or B
All Products from M1A1
with NFC1 A or B
N2B
All
Products
from N2B
Other Forms
All Products from M1A3
NSAIDS +
Coxibs
All Products
from M1A1
and M1A3
Oral Forms
All Products from M1A1
Takeda
Segment 2
Takeda
Segment
Market
Total Forms
Xefo Market
<BB_TITLE>
<DATA_TO>
Azilsartan Market Definitions
Takeda
Segment
Market
Azilsartan Market
C09C and C09D
Mono
Where ATC3 = C09C
Combi
Where ATC3 = C09D
<BB_TITLE>
<DATA_TO>
Takeda
Segment
Market
Candesartan Market Definitions
Candesartan Market
C09C and C09D
Mono
Where ATC3 = C09C
Combi
Where ATC3 = C09D
<BB_TITLE>
<DATA_TO>
Takeda
Segment
Market
Lansoprazole Market Definitions
Lansoprazole Market
A2B2
PPI
All A2B2 combinations of the following
molecules: pantoprazole, esomeprazole,
omeprazole, rabeprazole, lansoprazole,
dexlansoprazole
A2B2 Others
All remaining A2B2
<BB_TITLE>
<DATA_TO>
Leuprorelin Market Definitions
Market
Leuprorelin GnRH Analogues Market
All combinations of the following molecules: leuprorelin,
goserelin, histrelin, triptorelin, degarelix, buserelin
Limited to NFCs starting with F or G and NFC AAZ
The following Molecule and International Strength combinations are excluded :
Buserelin 1.05mg/1ml, Buserelin 1.14mg/1ml, Buserelin 100Y/Dose, Buserelin 150Y/Dose
Buserelin 182Y/1ml, Buserelin 1mg /1ml, Goserelin + Bicaltamide VARI STR, Triptorelin 1.88mg/1ml,
Triptorelin 100Y, Triptorelin 100Y/1ml, Triptorelin 105Y/1ml and Triptorelin 500Y/1ml
<BB_TITLE>
<DATA_TO>
Pioglitazone Market Definitions
Takeda
Segment 2
Takeda
Segment
Market
Pioglitazone Market
Where ATC3 = A10H, A10J, A10K, A10L, A10M, A10N, A10S
DPP-4 + GLP-1 + TZD
Where ATC3 = A10K, A10N, A10S
Pioglitazone Mono
Where ATC4 = A10H0,
A10J1, A10K1, A10L0
A10M1, A10N1, A10S0
All Other
Where ATC3 = A10H, A10J, A10L, A10M
Pioglitazone Combi
Where ATC4 = A10J2,
A10K2, A10K3, A10M3
A10N3
The following Molecule and International Strength Combinations are excluded :
Astragalus + Glibenclamide + Rehmania + Trichosanthes Combi Str, Thiopropazate 3.5mg, Thiopropazate 1.75mg,
Thiopropazate 1mg, Astragalus Membranaceus + Glibenclamide + Rehmania + Trichosanthes Combi Str, Glycyclamide 500mg,
Composition Unknown NA INTSTR, Glisolamide 5mg, Phenformin 25mg, Phenformin 50mg, Glibenclamide + Phenformin 5mg
+25mg, Glibenclamide + Phenformin 2.5mg+25mg, Glibenclamide + Phenformin 2mg+30mg, Tolbutamide 400mg+125mg,
Ascorbic Acid + Cyanocobalamin + Pangamic Acid + Phenformin + Pyridoxine + Riboflavin + Thiamine + Tolbutamide Combi Str,
Glibenclamide 2.5mg+500mg, Glibenclamide 2.5mg+400mg, Glibenclamide 2.5mg+12.5mg

similar documents